Jazz Pharmaceuticals Financials

Values in thousands	2026-06-30	2026-03-31	2025-12-31	2025-09-30
Revenue	$1,208,300	$1,068,900	$1,197,926	$1,126,107
Gross Profit	1,091,900	762,500	1,173,278	868,347
EBITDA	418,100	543,900	278,559	235,857
EBIT	248,100	362,500	253,687	57,611
Net Income	192,800	293,100	203,451	251,412
Net Change In Cash	1,208,300	1,068,900	1,197,926	1,126,107
Free Cash Flow	397,600	388,500	296,789	459,441
Cash	1,619,800	1,844,300	1,391,899	1,236,070
Basic Shares	69,400	66,099	60,984	61,606

Values in thousands	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue	$4,267,586	$4,068,950	$3,834,204	$3,659,374
Gross Profit	3,764,290	3,623,237	3,398,627	3,118,857
EBITDA	108,460	1,521,711	1,449,422	1,468,615
EBIT	-433,540	861,644	810,726	839,144
Net Income	-356,148	560,120	414,832	-224,060
Net Change In Cash	4,267,586	4,068,950	3,834,204	3,659,374
Cost of Revenue				296,256
Free Cash Flow	1,146,021	1,347,838	1,068,045	773,783
Cash	1,391,899	2,412,864	1,506,310	881,482
Basic Shares	60,984	66,007	72,066	62,539